Intervention not reported
Pain intensity (proxy‐rated) · people with dementia and mild to moderate pain
1 finding from 1 review
Intervention not reported
Challenging behaviour · people with dementia and mild to moderate pain
1 finding from 1 review
Intervention not reported
Number of people with adverse events · people with dementia and mild to moderate pain
1 finding from 1 review
Intervention not reported
Number of people with serious adverse events · people with dementia and mild to moderate pain
1 finding from 1 review
Intervention not reported
Quality of life · people with dementia and mild to moderate pain
1 finding from 1 review
Intervention not reported
Performance of activities of daily living · people with dementia and mild to moderate pain
1 finding from 1 review
Cognitive function · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Memory (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Executive function (specific cognitive function) · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Activities of daily living · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Quality of life, · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Combined cognitive‐functional outcome · Apathy in people with mild‐to‐moderate Alzheimer's disease
1 finding from 1 review
Any adverse events · Apathy in people with mild‐to‐moderate Alzheimer's disease
Souvenaid showed no clear difference in any adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Clinical Global (CIBIC+) · Alzheimer's disease (AD), moderate‐to‐severe
1 finding from 1 review
Intervention not reported
Clinical Global: (CIBIC+) · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Cognitive function: ADAS‐Cog 70‐point scale · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Performance on ADL (NOSGER self care subscale) Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Behaviour: NOSGER disturbing behaviour subscale Subscale 5 points · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review
Intervention not reported
Binary outcomes · vascular dementia, mild‐to‐moderate severity
The review found no eligible studies for this question.
1 finding from 1 review
Memantine for dementia 2019 · Cochrane Headline outcomes only no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause discontinuation · vascular dementia, mild‐to‐moderate severity
1 finding from 1 review